Key result
This editorial highlights the shift toward an integrated cardio-renal-metabolic approach, emphasizing multidimensional risk stratification, the metabolic context of interventions, and pleiotropic pharmacotherapies.
Highlights the paradigm shift towards managing cardiovascular, renal, and metabolic diseases as an interconnected continuum rather than isolated entities.
No takes yet. Share an insight, caveat, or question.
Theofilis et al. (2026) conducted an editorial in Cardiometabolic diseases (Diabetes, Hypertension, Cardiovascular Diseases). Cardiometabolic therapies and interventions (Special Issue review) was evaluated. This editorial highlights the shift toward an integrated cardio-renal-metabolic approach, emphasizing multidimensional risk stratification, the metabolic context of interventions, and pleiotropic pharmacotherapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: